It was demonstrated that mutations in the different TP53 subdomains are associated with distinct clinical behaviour of HNSCC and, consequently, have a differential impact on the disease prognosis in HNSCC subgroups (oral cavity, oropharynx, hypopharynx, and larynx) [27]. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.